[Neurological catastrophes in demyelinating diseases]. (Q27690899)

Guzmán de Villoria Lebiedziejewski J

series ordinal

2

1 reference

language of work or name

Spanish

0 references

publication date

October 2010

1 reference

1 reference

25 Suppl 1

1 reference

page(s)

30-6

1 reference

The pathological spectrum of CNS inflammatory demyelinating diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Multiple sclerosis: pseudotumoral forms

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Fulminant monophasic multiple sclerosis, Marburg's type

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Post-infectious encephalitis in adults: diagnosis and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Malignant monophasic multiple sclerosis or "Marburg's disease"

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Borderlines types of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute fulminant demyelinating disease: a descriptive study of 60 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Estimation of the cost of MS in Europe: extrapolations from a multinational cost study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Clinical prognostic factors in multiple sclerosis: a natural history review

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

A new scale for evaluating disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

An autopsy case of acute multiple sclerosis (Marburg's type) during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Marburg type and Bal�?s concentric sclerosis: rare and acute variants of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Establishing preconditions for Baló's concentric sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Balo's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Vanishing Balò-like lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Embolia cutis medicamentosa following interferon beta injection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Development of oral cladribine for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Determinants of survival in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Diagnosis and treatment of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

The borderland of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Recurrent myelitis and optic neuritis in a 29-year-old woman

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Neuromyelitis optica IgG status in acute partial transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Fulminant Devic disease successfully treated by lymphocytapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

ADEM: distinct disease or part of the MS spectrum?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Recurrence of acute disseminated encephalomyelitis at the previously affected brain site

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Leukodystrophies with late disease onset: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute disseminated encephalomyelitis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

The clinical course of acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute hemorrhagic leukoencephalitis mimicking herpes simplex encephalitis: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

Acute hemorrhagic leukoencephalitis. A successful recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0213-4853%2810%2970048-7

7 January 2021

10.1016/S0213-4853(10)70048-7

Identifiers

DOI

1 reference

PubMed publication ID

21129595

1 reference